Sotera Health Company Common Stock (SHC) is a publicly traded Healthcare sector company. As of May 20, 2026, SHC trades at $15.54 with a market cap of $4.38B and a P/E ratio of 37.65. SHC moved +2.04% today. Year to date, SHC is -15.03%; over the trailing twelve months it is +21.29%. Its 52-week range spans $9.53 to $19.85. Analyst consensus is strong buy with an average price target of $22.17. Rallies surfaces SHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SHC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SHC recently traded at $15.54. Market cap is $4.38B. P/E ratio is 37.65. Revenue is $1.19B.
| Metric | Value |
|---|---|
| Price | $15.54 |
| Market Cap | $4.38B |
| P/E Ratio | 37.65 |
| EPS | $0.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.85 |
| 52-Week Low | $9.53 |
| Volume | 2.12M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.19B |
| Net Income | $117.80M |
| Gross Margin | 55.26% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.16B | $77.95M | $0.27 |
| 2024 | $1.10B | $44.40M | $0.16 |
| 2023 | $1.05B | $51.38M | $0.18 |
| 2022 | $1.00B | $-233.57M | $-0.83 |
6 analysts cover SHC: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.17.